Approval · Notice of Compliance 6287 · 2005
IPRAMOL: Notice of Compliance 6287
Issued February 14, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6287
- Date
- February 14, 2005
- Company
- Ivax Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Bronchodilator
- Canadian reference product
- COMBIVENT
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPRAMOL | 02264609 | Cancelled Pre Market |
Medicinal ingredients
- IPRATROPIUM BROMIDE 0.5 MG per 2.5ML
- SALBUTAMOL SULFATE 2.5 MG per 2.5ML